AngioDynamics (ANGO) Reports Q2 In-Line; Guides

January 6, 2009 4:08 PM EST Send to a Friend
AngioDynamics (Nasdaq: ANGO) reports Q2 EPS of $0.12, versus the analyst estimate of $0.12. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login